PLGA-nanoparticles modified with anti-HER-2 affibody for enhance anti-tumor drug delivery

被引：0
|
作者：
Komedchikova, E. [1 ]
Shipunova, V. [1 ]
Babenyshev, A. [2 ]
Deev, S. [1 ]
机构：
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[2] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia
来源：
FEBS OPEN BIO | 2019年 / 9卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-36-053
引用
收藏
页码：387 / 387
页数：1
相关论文
共 50 条
  • [1] PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death
    Shipunova, Victoria Olegovna
    Sogomonyan, Anna Samvelovna
    Zelepukin, Ivan Vladimirovich
    Nikitin, Maxim Petrovich
    Deyev, Sergey Mikhailovich
    MOLECULES, 2021, 26 (13):
  • [2] PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System
    Allavena, Paola
    Palmioli, Alessandro
    Avigni, Roberta
    Sironi, Marina
    La Ferla, Barbara
    Maeda, Akihiro
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2020, 16 (02) : 212 - 223
  • [3] MR molecular imaging of HER-2 in a murine tumor xenograft by SPIO labeling of anti-HER-2 affibody
    Kinoshita, Manabu
    Yoshioka, Yoshichika
    Okita, Yoshiko
    Hashimoto, Naoya
    Yoshimine, Toshiki
    CONTRAST MEDIA & MOLECULAR IMAGING, 2010, 5 (01) : 18 - 22
  • [4] PLGA Nanoparticles for Anti Tuberculosis Drug Delivery
    Malathi, S.
    Balasubramanian, S.
    RECENT TRENDS IN ADVANCED MATERIALS, 2012, 584 : 465 - 469
  • [5] Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery
    Li, Mengqian
    Zhao, Guangkuo
    Su, Wei-Ke
    Shuai, Qi
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [6] KD5005: HER-2 dependent strong potent anti-tumor activity of an anti-HER-2 mAb TNFaimmunocytokine
    Chen, Yi
    Li, Peng
    Fang, Guobo
    Wu, Heng
    Zhang, Chi
    Cai, Zeling
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Multifunctional modified carbon nanotubes as potential anti-tumor drug delivery
    Carneiro, Pedro Gontijo
    Pereira, Duane Gischewski
    da Silva, Bruno Milton Oliveira
    Ribeiro, Helio
    Barbosa, Leandro Augusto
    Villar, Jose Augusto Ferreira Perez
    Schnitzler, Mariane Cristina
    SURFACES AND INTERFACES, 2023, 41
  • [8] Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer
    Li, Shu
    Li, Xiaofeng
    Ding, Jianyi
    Han, Lingfei
    Guo, Xiaoqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1271 - 1280
  • [9] Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer
    Subramaniam, Sugarniya
    Jeet, Varinder
    Gunter, Jennifer H.
    Khan, Taskeen Janjua
    Feng, Yuran
    Clements, Judith A.
    Srinivasan, Srilakshmi
    Popat, Amirali
    Batra, Jyotsna
    CANCER LETTERS, 2025, 616
  • [10] In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics
    Steffen, AC
    Wikman, M
    Tolmachev, V
    Adams, GP
    Nilsson, FY
    Ståhl, S
    Carlsson, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2005, 20 (03) : 239 - 248
12345